Individualising Antibiotic Dosing in Critically Ill Patients with Acute Kidney Injury: Pharmacokinetic and Pharmacodynamic Challenges

Acute kidney injury (AKI) is common in critically ill patients and alters the handling of renally cleared antibiotics, while sepsis adds unpredictable changes in volume of distribution, protein binding and organ perfusion. Renal dosing recommendations derived from stable chronic kidney disease can leave patients underexposed early in infection, whereas later drug accumulation drives neurotoxicity and nephrotoxicity. This review examines the pharmacokinetic and pharmacodynamic basis for individualised antibiotic dosing in AKI, compares loading with maintenance strategies, and considers the limits of creatinine-based estimates, renal replacement therapy, therapeutic drug monitoring and toxicity. Much of the supporting evidence is pharmacokinetic or observational, and randomised trials of dose adjustment in AKI are lacking. We therefore propose a stepwise framework for clinical judgement: full loading doses, prolonged β-lactam infusion, reassessment of maintenance doses at 24 to 48 hours, and concentration monitoring where available. Practical implications for Indian intensive care units and for clinical pharmacists are discussed.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-20
DOI
https://doi.org/10.5281/zenodo.24394380
Primary Topic
Antibiotics Pharmacokinetics and Efficacy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Individualising Antibiotic Dosing in Critically Ill Patients with Acute Kidney Injury: Pharmacokinetic and Pharmacodynamic Challenges

Abinash. K., Monica. K., Manisha. M.
Zenodo (CERN European Organization for Nuclear Research)
Antibiotics Pharmacokinetics and Efficacy
article

Individualising Antibiotic Dosing in Critically Ill Patients with Acute Kidney Injury: Pharmacokinetic and Pharmacodynamic Challenges

Abinash. K., Monica. K., Manisha. M.
article en

Abstract

Acute kidney injury (AKI) is common in critically ill patients and alters the handling of renally cleared antibiotics, while sepsis adds unpredictable changes in volume of distribution, protein binding and organ perfusion. Renal dosing recommendations derived from stable chronic kidney disease can leave patients underexposed early in infection, whereas later drug accumulation drives neurotoxicity and nephrotoxicity. This review examines the pharmacokinetic and pharmacodynamic basis for individualised antibiotic dosing in AKI, compares loading with maintenance strategies, and considers the limits of creatinine-based estimates, renal replacement therapy, therapeutic drug monitoring and toxicity. Much of the supporting evidence is pharmacokinetic or observational, and randomised trials of dose adjustment in AKI are lacking. We therefore propose a stepwise framework for clinical judgement: full loading doses, prolonged β-lactam infusion, reassessment of maintenance doses at 24 to 48 hours, and concentration monitoring where available. Practical implications for Indian intensive care units and for clinical pharmacists are discussed.

Zenodo (CERN European Organization for Nuclear Research)
Tamil Nadu Dr. M.G.R. Medical University (IN)
Good health and well-being
Antibiotics Pharmacokinetics and Efficacy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon
Individualising Antibiotic Dosing in Critically Ill Patients with Acute Kidney Injury: Pharmacokinetic and Pharmacodynamic Challenges — Abinash. K., Monica. K., et al. · Zenodo (CERN European Organization for Nuclear Research) (2026) | TGRS Research Map | TGRS